Federated Hermes
DTIL icon

Federated Hermes’s Precision BioSciences DTIL Stock Holding History

Federated Hermes’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-238
Closed -$5.38K – 2134
2023
Q1 		$5.38K Sell
238
-3,356
-93% -$111K ﹤0.01% 1925
2022
Q4 		$128K Sell
3,594
-3,093
-46% -$122K ﹤0.01% 1614
2022
Q3 		$261K Sell
6,687
-9
-0.1% -$428 ﹤0.01% 1478
2022
Q2 		$321K Buy
6,696
+605
+10% +$35.5K ﹤0.01% 1453
2022
Q1 		$563K Buy
6,091
+3,811
+167% +$518K ﹤0.01% 1418
2021
Q4 		$507K Buy
2,280
+937
+70% +$262K ﹤0.01% 1479
2021
Q3 		$465K Hold
1,343
– – ﹤0.01% 1519
2021
Q2 		$505K Buy
1,343
+1,206
+880% +$362K ﹤0.01% 1507
2021
Q1 		$43K Sell
137
-20
-13% -$7K ﹤0.01% 1884
2020
Q4 		$39K Buy
157
+4
+3% +$980 ﹤0.01% 1843
2020
Q3 		$28K Sell
153
-4
-3% -$796 ﹤0.01% 1853
2020
Q2 		$39K Sell
157
-10
-6% -$2.19K ﹤0.01% 1796
2020
Q1 		$30K Buy
167
+50
+43% +$13.1K ﹤0.01% 1750
2019
Q4 		$49K Sell
117
-117
-50% -$36.8K ﹤0.01% 1739
2019
Q3 		$59K Buy
+234
New +$76.2K ﹤0.01% 1705

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Federated Hermes's DTIL Position: Q2 2023 in Review

Federated Hermes sold out of Precision BioSciences (DTIL) in Q2 2023, closing a stake of 238 shares — an estimated $5.38K sold.

Federated Hermes first reported a position in DTIL in Q3 2019 and held it in 15 quarters. The position peaked at $563K in Q1 2022. 77 funds tracked by Wall St. Rank hold DTIL as of Q2 2023.

  • Federated Hermes reported no remaining Precision BioSciences position as of Q2 2023 after selling out during the quarter.
  • Federated Hermes sold 238 Precision BioSciences shares in Q2 2023, an estimated $5.38K.
  • Federated Hermes first reported a position in Precision BioSciences in Q3 2019 and held it in 15 quarters.
  • Federated Hermes's Precision BioSciences position peaked at $563K in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.